2026 年至 2032 年无创血糖监测设备市场（按产品类型、通路、最终用户和地区）

2026-2032年非侵入性血糖监测设备市场评估

非侵入性血糖监测设备需求持续成长 近年来，随着糖尿病盛行率的不断上升，消费者也越来越意识到血糖监测设备的益处。疫情期间，虚拟诊所和远端医疗在治疗多种疾病（包括糖尿病）的应用显着增加。由于重症糖尿病及其他合併症住院患者数量众多，医院细分市场在全球血糖监测设备市场中占据终端用户细分市场的最高份额。预计2024年市场规模将超过3,701万美元，2032年将达3.2493亿美元。

非侵入性血糖监测设备使患者能够持续、无痛地监测血糖浓度。对具有先进功能的智慧糖尿病管理设备的需求预计将推动市场成长。对经济高效的非侵入性血糖监测设备的需求不断增长，推动市场在2026年至2032年间以31.20%的复合年增长率成长。

非侵入性血糖监测设备市场定义/概述

血糖监测是使用血糖仪测量血液中的血糖浓度（血糖值）。血糖值检测在糖尿病治疗中尤其重要，通常透过刺穿皮肤（通常用指尖刺破）来获取血液样本，并将其滴到具有化学活性的抛弃式上进行。

血糖监测设备是检测血糖值的重要工具，种类繁多，包括血糖仪、试纸和采血针。这些设备可方便患者在家中轻鬆测量血糖值，并对治疗方案进行必要的调整。这采血针患者及其医生能够识别血糖值高低，并对治疗方案进行必要的调整。血糖监测设备彻底改变了糖尿病治疗，使患者能够更好地掌控自身健康，并降低急性低血糖和高血糖的风险。

非侵入性血糖监测设备可测量糖尿病患者的血糖值。非侵入性血糖监测无需刺穿皮肤，也不会带给使用者疼痛或创伤。非侵入性检测血糖浓度有助于改善糖尿病患者的血糖控制和生活品质。此外，它还可用于治疗第1型和第2型糖尿病患者。

糖尿病盛行率的上升将如何影响非侵入性血糖监测市场？

非侵入性血糖监测市场日益普及：糖尿病在全球日益普遍，直接影响着非侵入性血糖监测设备市场的成长。如果高血糖得不到有效控制，可能会对器官和组织造成长期损害。血糖值监测对于糖尿病管理至关重要，因为它可以让患者和医护人员准确地了解过去2-3个月的整体血糖控制。

糖尿病盛行率的上升可能会在预测期内推动全球非侵入式血糖监测设备市场的成长。美国糖尿病协会 (ADA) 建议，对于达到治疗目标且血糖控制稳定的患者，应至少每年测量两次糖化血红蛋白 (HbA1c) 水平；对于药物已更改或血糖未达到目标的患者，应每季度测量一次。

根据国际糖尿病联盟的数据，2021年约有5.2亿20至79岁的人患有糖尿病，预计到2045年这一数字将上升到7亿。全球超过90%的糖尿病患者患有第2型糖尿病。

哪些因素限制了非侵入性血糖监测的需求？

最重要的因素是非侵入性血糖监测仪 (NIBGM) 的日益普及。准确性和可靠性对于糖尿病患者的治疗至关重要。目前，NIBGM 设备可能并不总是像传统方法那样准确，这引起了依赖高精度数据的用户的担忧。

糖尿病患者已经形成了既定的治疗习惯，并习惯使用一些老方法。切换到一项新技术，尤其是准确性可能存疑的技术，可能会令人感到担忧。除非我们对NIBGM的准确性和易用性有信心，否则我们会谨慎地引入它。

非侵入性血糖监测设备通常比标准监测设备更昂贵。这可能是一个重大障碍，尤其是对于经济资源有限或保险覆盖较差的患者。初始投资成本可能会使 NIBGM 对某些人缺乏吸引力。

目录

第一章 引言

• 市场定义
• 市场区隔
• 调查方法

第二章执行摘要

• 主要发现
• 市场概览
• 市集亮点

第三章市场概述

• 市场规模和成长潜力
• 市场趋势
• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析

第四章。非侵入性血糖监测设备市场（按最终用户）

• 医院
• 诊所
• 诊断中心
• 家庭医疗保健

5. 非侵入性血糖监测设备市场（依分销管道）

• 零售
• 专卖店
• 药局/药房
• 在线的

6. 非侵入性血糖监测设备市场（依产品类型）

• 自我监测血糖设备
• 血糖试纸
• 血糖仪
• 《采血针》
• 连续血糖监测设备

第七章区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯聯合大公国

第八章市场动态

• 市场驱动因素
• 市场限制
• 市场机会
• COVID-19 市场影响

第九章 竞争态势

• 主要企业
• 市场占有率分析

第十章 公司简介

• Abbott Laboratories
• DexCom
• Tech4Life Enterprises
• Integrity Applications. Inc.
• Hoffmann-La Roche Ltd
• MediWise
• Medtronic
• Nemaura
• OrSense
• Taiwan Biophotonic Corporation

第十一章 市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第十二章 附录

• 简称列表
• 来源和参考文献

Non-Invasive Blood Glucose Monitoring Devices Market Valuation - 2026-2032

Rising demand for non-invasive blood glucose monitoring devices consumers have been more aware of the benefits of blood glucose monitoring devices in recent years as the prevalence of diabetes has increased. During the pandemic, there was a significant increase in the use of virtual clinics and telemedicine to treat multiple illnesses including diabetes care. The hospital segment accounted for the highest proportion of the worldwide glucose monitoring devices market's end-user segment, as many patients are admitted due to severe diabetes and other concurrent conditions. The market size surpass USD 37.01 Million valued in 2024 to reach a valuation of around USD 324.93 Million by 2032.

Non-invasive blood glucose monitoring devices provide continuous, painless surveillance of a patient's glucose levels. Demand for smart diabetes management devices with advanced features is expected to boost the market. The rising demand for cost-effective and efficient non-invasive blood glucose monitoring devices is enabling the market grow at a CAGR of 31.20% from 2026 to 2032.

Non-Invasive Blood Glucose Monitoring Devices Market: Definition/ Overview

Blood glucose monitoring is the use of a glucose monitor to determine the level of glucose in the blood (glycemia). A blood glucose test, which is especially crucial in diabetes treatment, is commonly performed by piercing the skin (usually with a fingerstick) and drawing blood, which is then applied to a chemically active disposable.

Glucose monitoring devices are an essential tool for detecting the sugar level in the blood, and they come in various types, including glucose meters, testing strips, and lancets. With the help of these devices, people can easily test their blood glucose levels at home and make necessary adjustments to their therapy. This allows individuals and their doctors to identify high or low blood glucose levels and make necessary changes to their treatment plan. Glucose monitoring devices have revolutionized diabetes care by offering patients greater control over their health and reducing the risk of acute hypoglycemia or hyperglycemia.

Non-invasive blood glucose monitoring devices measure blood glucose levels in diabetic individuals. Non-invasive glucose monitoring involves measuring blood without piercing the skin or causing pain or trauma to the consumer, which is why non-invasive gadgets are so popular. Non-invasive detection of blood glucose concentration improves blood sugar control and the quality of life for diabetics. Furthermore, it is utilized to treat both Type 1 and Type 2 diabetic patients.

How will Rising Prevalence of Diabetes Affect Non-Invasive Blood Glucose Monitoring Market?

Rising Prevalence in non-invasive blood glucose monitoring market, Diabetes has grown more common around the world, which has a direct impact on the growth of the non-invasive blood glucose monitoring equipment market. If high blood sugar is not effectively controlled it can cause long-term harm to organs and tissues. Monitoring blood sugar levels has become critical for diabetes management since it gives patients and healthcare professionals an accurate view of overall blood sugar control over the previous 2-3 months.

The rising prevalence of diabetes is likely to drive the growth of the global non-invasive blood glucose monitoring devices market over the predicted period. The American Diabetes Association (ADA) recommends measuring HbA1c levels at least twice a year for patients who are meeting treatment objectives and have stable glycemic control, and quarterly for patients whose medication has changed or who are not meeting glycemic goals.

According to the International Diabetes Federation, roughly 520 million persons aged 20 to 79 had diabetes in 2021, and this figure is anticipated to climb to 700 million by 2045. Type 2 diabetes accounts for more than 90% of diabetes cases worldwide.

What are the Factors Restraining Demand for Non-Invasive Blood Glucose Monitoring Market?

The most significant factor is are expanding prevalence of non-invasive blood glucose monitor (NIBGM), it is a very new technology as compared to older finger-prick procedures. Accuracy and dependability are critical for diabetics in treating their condition. Currently, NIBGM devices may not always equal the precision of older methods, raising concerns among users who rely on extremely accurate data.

People with diabetes have established routines and are familiar with older procedures. Switching to a new technology, particularly one with potential accuracy issues can be scary. They may be cautious to adopt NIBGM unless they have trust in its accuracy and usability.

Non-Invasive blood glucose monitoring devices are typically more expensive than standard monitors. This can be a substantial hurdle for patients especially those with little financial resources or insufficient insurance coverage. The initial investment expense may make NIBGM less appealing for some.

Category-Wise Acumens

How the Segment Self-Monitoring Device will Dominate the Non-Invasive Blood Glucose Monitoring Devices Market?

The self-monitoring devices segment is substantially leading the non-invasive blood glucose monitoring devices market owing to the catering to individuals with diabetes who require regular monitoring of their blood sugar levels. This market includes a variety of self-testing products, such as glucose strips, glucose meters, and lancets. These devices enable diabetics to easily and accurately monitor their glucose levels at home, allowing them to make educated decisions regarding their diabetes treatment routine.

Glucose meters are booming the non-invasive blood glucose monitoring devices market, glucose meters are handheld electronic devices used to measure and display blood glucose levels based on the readings obtained from glucose strips. These meters play a critical role in self-monitoring blood glucose devices, providing users with real-time feedback on their glucose levels. The glucose meter segment is characterized by ongoing technological advancements aimed at improving accuracy, speed, and user-friendliness. Key features such as wireless connectivity, data storage, and compatibility with mobile apps are increasingly incorporated into glucose meters to enhance usability and convenience for individuals managing diabetes.

How will the Home Healthcare and Hospitals Segment Control the Non-Invasive Blood Glucose Monitoring Devices Market?

The home healthcare segment dominates the market for non-invasive blood glucose monitoring devices, the hospital segment is seeing significant growth opportunities due to increased adoption of advanced monitoring technologies and a growing emphasis on improving diabetes management in healthcare facilities.

Due to a number of factors, including an increase in the global prevalence of diabetes, a greater emphasis on patient-centered care, and a growing desire for convenient and accessible monitoring systems. Individuals with diabetes prefer the convenience and privacy of monitoring their blood glucose levels at home rather than frequent visits to healthcare institutions. Non-invasive blood glucose monitoring devices designed for home usage provide ease of use, portability, and real-time data tracking, empowering patients to efficiently manage their condition between healthcare consultations.

While the home healthcare segment leads the industry, the hospital segment is rapidly expanding and deemed thriving. Hospitals continue to be significant end users of non-invasive blood glucose monitoring devices, particularly for diabetes management in hospitalized patients and those requiring intensive care.

Country/Region-wise Acumens

How Does North America Emerge the Non-Invasive Blood Glucose Monitoring Devices Market?

North America emerges as the leading force in the projected market for non-invasive blood glucose monitoring devices, in 2019, North America led the global market for non-invasive blood glucose monitoring devices by revenue, followed by Europe. The region's huge market share can be due to its high disease prevalence and well-established healthcare infrastructure, which allows for accurate diagnosis. In 2018, the American Diabetes Association reported that 34.2 million people in the United States had diabetes, accounting for 10.5% of the population. Type 1 diabetes affects 1.6 million people, including around 187,000 children and adolescents.

North America's dominance in the predicted market for non-invasive blood glucose monitoring devices is due to excellent reimbursement policies, greater diabetes awareness, well-developed healthcare infrastructure, and a supportive regulatory environment. As these factors continue to drive demand and acceptance, North America is expected to maintain its dominance in the global market for non-invasive blood glucose monitoring devices.

Will Non-Invasive Blood Glucose Monitoring Devices Market Witness Rapid Growth in Asia Pacific?

The Asia Pacific market is poised to grow rapidly during the projected period, driven primarily by the rising prevalence of diabetes and increased knowledge about its diagnosis and treatment. This increase in diabetes prevalence is especially noticeable in Asia Pacific, where the majority of countries are experiencing rapid economic growth. As a result, many healthcare companies are making significant investments in the region to capitalize on the growing demand for non-invasive blood glucose monitoring devices and related technology. These collaborative efforts are critical in driving the market's growth throughout Asia Pacific.

According to data from the International Diabetes Federation (IDF), the prevalence of diabetes is increasing in developing nations, owing to rapid and ongoing socioeconomic changes. This trend is projected to continue, driving up demand for non-invasive blood glucose monitoring devices in Asia Pacific.

As the region's economies mature and healthcare infrastructure improves, there is an increasing need to treat the rising diabetes burden. As a result, the combination of rising illness prevalence, increased awareness, and significant investments highlights the non-invasive blood glucose monitoring devices market's enormous growth potential in Asia Pacific.

Competitive Landscape

The non-invasive blood glucose monitoring devices market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the non-invasive blood glucose monitoring devices market include:

• DiaMonTech GmbH
• Nemaura Medical, Inc.
• Integrity Applications, Inc.
• CNOGA Medical Ltd.
• Breath Health, Inc.
• Metamaterial Technologies, Inc.
• Opticology, Inc.
• NovioSense BV
• Quick LLC
• RSP Systems A/S
• Abbott (U.S.)
• GlySens Incorporated
• Novo Nordisk
• PHC Holdings Corporation
• TaiDoc Technology Corporation
• AgaMatrix
• Dexcom, Inc.

Latest Developments

• In May 2024, Abbott announced new programs aimed at increasing diversity in medical trials and improving care for underrepresented communities.
• In June 2024, Know Labs, a medical diagnostic business, plans to launch the first commercially available non-invasive glucose monitor, the Generation 1 gadget.

In May 2019, Nemaura got a CE mark for SugarBEAT, a non-invasive continuous glucose monitoring device, for sale in EU territories.Non-Invasive Blood Glucose Monitoring Devices Market, By Category

• Product Type:
• Self-Monitoring Blood Glucose Devices
• Glucose strips
• Glucose meter
• Lancets
• Continuous Glucose Monitoring Devices
• Distribution Channel:
• Retail
• Specialty Stores
• Drug Stores/Pharmacies
• Online
• End-User:
• Hospital
• Clinics
• Diagnostic Centers
• Home Healthcare
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Non-Invasive Blood Glucose Monitoring Devices Market, By End-User:

• Hospital
• Clinics
• Diagnostic Centers
• Home Healthcare

5. Non-Invasive Blood Glucose Monitoring Devices Market, By Distribution Channel:

• Retail
• Specialty Stores
• Drug Stores/Pharmacies
• Online

6. Non-Invasive Blood Glucose Monitoring Devices Market, By Product Type

• Self-Monitoring Blood Glucose Devices
• Glucose strips
• Glucose meter
• Lancets
• Continuous Glucose Monitoring Devices

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Abbott Laboratories
• DexCom
• Tech4Life Enterprises
• Integrity Applications. Inc.
• Hoffmann-La Roche Ltd
• MediWise
• Medtronic
• Nemaura
• OrSense
• Taiwan Biophotonic Corporation

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References